15th Annual Optimising Clinical Trials Summit: Site Selection, Feasibility and Patient Recruitment


Without any warning, the pandemic has turned the world of clinical trials and clinical operations on its head. The result is more than clear: re-evaluate how to manage this field more effectively with a significant impact on patients’ monitoring and data collection. We can see the huge change in study planning and necessity for adoption of new technologies with decentralised trials in the foreground. Let us reveal the details and what is beyond of current studies in order to bring the new therapies on the market and support the patients in the most effective way.

The 15th Annual Optimising Clinical Trials Summit: Site Selection, Feasibility & Patient Recruitment was designed in order to discuss the main trends and current challenges occurring in the pharma world. Senior-level experts from top pharma companies will be sharing their professional insights and experiences related to the new clinical trials formats, rare disease trials and their best approaches, patient safety perspectives, building and implementing data-driven site selection approaches, wearables clinical trials, what are the difficulties in reaching patient population, risks and benefits from a scientific and an operational perspective and much more. This unique pharma business meeting will allow you to look beyond the internal strategies of the top players on the market, and provide a global stage like no other with great networking opportunities. 

The clinical trials pharma event gives you an excellent selection of C-level decision-makers, an opportunity to develop important business contacts and access to internal projects. Our pharma conference is highly interactive and due to limited seats and a friendly atmosphere, you will enjoy the most interactive environment and valuable discussions.

Join us and register today

Stay on top of the latest trends

Key speakers

Marta <br><b>GARCIA MANRIQUE</b>

Marta
GARCIA MANRIQUE

Chief Patient Officer, R&D
Nadia <br><b>LIM</b>

Nadia
LIM

Director, Site Intelligence
Wolfgang <br><b>SUMMA</b>

Wolfgang
SUMMA

Head of CMO Informatics, Biopharma, R&D Informatics
Jost <br><b>LEEMHUIS</b>

Jost
LEEMHUIS

Head of Safety Science
Karl-Ludwig <br><b>RADEK</b>

Karl-Ludwig
RADEK

Ass. Director Global Clinical Operations
Terttu <br><b>HARING</b>

Terttu
HARING

Global Head for Clinical Innovation


Key topics

  • Perspectives on how global pandemic impacted the clinical research field
  • Technologies and AI-enabled solutions in clinical trial feasibility and site selection
  • What is the clinical trial’s greatest enemy?
  • Shifts in clinical trial transparency regulations and expectations for the future?
  • How to use decentralised trials for study design optimisation?
  • Barriers to pharma companies’ R&D efforts
  • How the pharma industry’s use of trials has changed since the pandemic hit?
  • Current clinical data concepts and views
  • What are the needs during the drug development?



Who Should Attend

Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharma industry involved in:

  • Clinical Trials
  • Clinical Operations
  • Clinical Information
  • Clinical Development
  • Outsourced Trials
  • Clinical Study
  • Safety Science
  • Site Intelligence
  • Patient Centricity
  • Data Scientists
  • R&D Informatics
  • Clinical Innovations
  • Site Management
  • Clinical Management
  • Clinical Research
  • Global Safety
  • Risk Monitoring
  • Data Integrity
  • Feasibility
  • Patient Recruitment